{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:10:45Z","timestamp":1765807845915,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.10.052","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T18:36:38Z","timestamp":1605724598000},"page":"45-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Economic evaluation of the introduction of rotavirus vaccine in Hong Kong"],"prefix":"10.1016","volume":"39","author":[{"given":"Karene Hoi Ting","family":"Yeung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"McGhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara Bess","family":"Janusz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Atherly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Anthony S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2020.10.052_b0005","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.052_b0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years","volume":"172","author":"Troeger","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"192 Suppl 1","key":"10.1016\/j.vaccine.2020.10.052_b0015","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/431492","article-title":"Estimates of rotavirus disease burden in Hong Kong: hospital-based surveillance","volume":"1","author":"Nelson","year":"2005","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2020.10.052_b0020","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.vaccine.2014.01.065","article-title":"Rotavirus incidence in hospitalised Hong Kong children: 1 July 1997 to 31 March 2011","volume":"32","author":"Chiang","year":"2014","journal-title":"Vaccine"},{"issue":"192 Suppl 1","key":"10.1016\/j.vaccine.2020.10.052_b0025","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/431493","article-title":"Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong","volume":"1","author":"Nelson","year":"2005","journal-title":"J Infect Dis"},{"issue":"30","key":"10.1016\/j.vaccine.2020.10.052_b0030","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1016\/j.vaccine.2012.03.030","article-title":"Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population","volume":"30","author":"Phua","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.052_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.052_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"41","key":"10.1016\/j.vaccine.2020.10.052_b0045","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1016\/j.vaccine.2016.08.047","article-title":"Rotavirus vaccine effectiveness in Hong Kong children","volume":"34","author":"Yeung","year":"2016","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.052_b0050","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/infdis\/jir492","article-title":"Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States","volume":"204","author":"Lopman","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.052_b0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/infdis\/jix589","article-title":"Trends in rate of seizure-associated hospitalizations among children <5 years old before and after rotavirus vaccine introduction in the United Sates, 2000\u20132013","volume":"217","author":"Pringle","year":"2018","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.052_b0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/cit671","article-title":"Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children","volume":"58","author":"Payne","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.052_b0065","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/jech-2019-213055","article-title":"Reduction in hospitalisations for acute gastroenteritis-associated childhood seizures since introduction of rotavirus vaccination: a time-series and change-point analysis of hospital admissions in England","volume":"2","author":"Hungerford","year":"2019","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.vaccine.2020.10.052_b0070","unstructured":"World Health Organization. Rotavirus vaccines: WHO position paper - January 2013. World Health Organization; 2013. Report No.: 5."},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.052_b0075","first-page":"23","article-title":"Immunisation coverage for children aged two to five: findings of the 2015 immunisation survey","volume":"14","author":"Chan","year":"2017","journal-title":"Commun Dis Watch"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.052_b0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/adc.2007.117879","article-title":"Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective","volume":"93","author":"Ho","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2020.10.052_b0085","unstructured":"World Health Organization. Generic protocol for monitoring impact of rotaviurs vaccination on gastroenteritis disease burden and viral strains. Report No.: WHO\/IVB\/08.16; 2008."},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.052_b0090","doi-asserted-by":"crossref","first-page":"e1541","DOI":"10.1016\/S2214-109X(19)30412-7","article-title":"Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules","volume":"7","author":"Clark","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.052_b0095","doi-asserted-by":"crossref","first-page":"e1664","DOI":"10.1016\/S2214-109X(19)30439-5","article-title":"Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study","volume":"7","author":"Debellut","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2020.10.052_b0100","unstructured":"United Nations DoEaSAPD2. World Population Prospects: The 2017 Revision; 2017."},{"issue":"62 Suppl 2","key":"10.1016\/j.vaccine.2020.10.052_b0105","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000\u20132013","volume":"1","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"46","key":"10.1016\/j.vaccine.2020.10.052_b0110","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1016\/j.vaccine.2013.08.103","article-title":"Cost-effectiveness of rotavirus vaccination programs in Taiwan","volume":"31","author":"Chang","year":"2013","journal-title":"Vaccine"},{"issue":"Mar","key":"10.1016\/j.vaccine.2020.10.052_b0115","article-title":"Update on the global epidemiology of intussusception: a systematic review of incidence rates, age distributions and case-fatality ratios among children aged <5 years, before the introduction of rotavirus vaccination","author":"Clark","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.052_b0120","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","article-title":"Disability weights for the Global Burden of Disease 2013 study","volume":"3","author":"Salomon","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2020.10.052_b0125","unstructured":"Centers for Disease Control and Prevention. The Pink Book: Rotavirus; 2018. https:\/\/www cdc.gov\/vaccines\/pubs\/pinkbook\/rota.html [accessed 2 Jun 2019]."},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.052_b0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S0950268898008747","article-title":"Rotavirus infection in Hong Kong: epidemiology and estimates of disease burden","volume":"120","author":"Chan","year":"1998","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2020.10.052_b0135","unstructured":"Hong Kong Intussusception Study Group. Intussusception trends in Hong Kong children. Hong Kong Med J 2007;13(4):279\u201383."},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.052_b0140","first-page":"518","article-title":"Childhood intussusception: 17-year experience at a tertiary referral centre in Hong Kong","volume":"21","author":"Wong","year":"2015","journal-title":"Hong Kong Med J"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.052_b0145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1473-3099(19)30126-4","article-title":"Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials","volume":"19","author":"Clark","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"47","key":"10.1016\/j.vaccine.2020.10.052_b0150","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1016\/j.vaccine.2010.08.060","article-title":"An update to \u201cThe cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe\u201d","volume":"28","author":"Jit","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2020.10.052_b0155","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/INF.0000000000001232","article-title":"A systematic review of the effect of rotavirus vaccination on diarrhea outcomes among children younger than 5 years","volume":"35","author":"Lamberti","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.052_b0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jpids\/piu097","article-title":"Febrile seizures in the era of rotavirus vaccine","volume":"5","author":"Sheridan","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"31","key":"10.1016\/j.vaccine.2020.10.052_b0165","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1016\/j.vaccine.2018.06.029","article-title":"Lack of impact of rotavirus vaccination on childhood seizure hospitalizations in England: an interrupted time series analysis","volume":"36","author":"Biggart","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.052_b0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpeds.2015.03.038","article-title":"Intussusception and monovalent rotavirus vaccination in Singapore: self-controlled case series and risk-benefit study","volume":"167","author":"Yung","year":"2015","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.052_b0175","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cit520","article-title":"Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program","volume":"57","author":"Carlin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"32","key":"10.1016\/j.vaccine.2020.10.052_b0180","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.vaccine.2016.04.050","article-title":"The risk of intussusception following monovalent rotavirus vaccination in England: a self-controlled case-series evaluation","volume":"34","author":"Stowe","year":"2016","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2020.10.052_b0185","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1016\/j.vaccine.2015.07.054","article-title":"Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008\u20132014","volume":"33","author":"Haber","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.052_b0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1303164","article-title":"Intussusception risk after rotavirus vaccination in U.S. infants","volume":"370","author":"Yih","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.10.052_b0195","unstructured":"Mc Ghee SM, Chau J, Wong LC, et al. Economic analysis on Haemophilus influenzae b, chickenpox, pneumococcal, hepatitis A and combination vaccines in the Childhood Immunisation Programme in Hong Kong. Research Fund for the Control of Infectious Diseases: Final Report; 2008."},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2020.10.052_b0200","doi-asserted-by":"crossref","first-page":"F97","DOI":"10.1016\/j.vaccine.2009.09.002","article-title":"Human rotavirus genotypes in hospitalized children, South Korea, April 2005 to March 2007","volume":"27","author":"Lee","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.052_b0205","unstructured":"World Health Organization. How to calculate vaccine volumes and cold chain capacity requirements; 2017. https:\/\/appswhoint\/iris\/bitstream\/handle\/10665\/255749\/WHO-IVB-1706-engpdf."},{"key":"10.1016\/j.vaccine.2020.10.052_b0210","unstructured":"Census and Statistics Department. Thematic Household Survey Report. Census and Statistics Department, Hong Kong Special Administrative Region. Report No.: Report No. 63; 2018."},{"key":"10.1016\/j.vaccine.2020.10.052_b0215","unstructured":"Department of Community Medicine SoPHTUoHK. Children's Telephone Survey; 2006."},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.052_b0220","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/1471-2458-11-462","article-title":"Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model","volume":"11","author":"Rozenbaum","year":"2011","journal-title":"BMC Public Health"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.052_b0225","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost-effectiveness thresholds: pros and cons","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.052_b0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1287\/ited.1080.0013","article-title":"Teaching Note - Teaching project simulation in excel using PERT-beta distributions","volume":"8","author":"Davis","year":"2008","journal-title":"INFORMS Trans Educ"},{"key":"10.1016\/j.vaccine.2020.10.052_b0235","unstructured":"World Bank. World Bank national accounts data, and OECD National Accounts data files; 2019. https:\/\/data worldbank org\/indicator\/NY GDP PCAP CD?locations=HK [accessed 18 Aug 2019]."},{"issue":"50","key":"10.1016\/j.vaccine.2020.10.052_b0240","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1016\/j.vaccine.2017.03.076","article-title":"The rotavirus vaccine development pipeline","volume":"37","author":"Kirkwood","year":"2019","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2020.10.052_b0245","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2020.10.052_b0250","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1016\/j.vaccine.2014.04.082","article-title":"Evaluating the potential risks and benefits of infant rotavirus vaccination in England","volume":"32","author":"Clark","year":"2014","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2020.10.052_b0255","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.50.17-00041","article-title":"A benefit-risk analysis of rotavirus vaccination, France, 2015","volume":"22","author":"Lamrani","year":"2017","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.052_b0260","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40259-018-0273-6","article-title":"Benefit versus risk assessment of rotavirus vaccination in France: a simulation and modeling analysis","volume":"32","author":"Ledent","year":"2018","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.052_b0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40264-015-0376-7","article-title":"Post-marketing benefit-risk assessment of rotavirus vaccination in Japan: a simulation and modelling analysis","volume":"39","author":"Ledent","year":"2016","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.052_b0270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12916-018-1134-3","article-title":"Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting","volume":"16","author":"Bruijning-Verhagen","year":"2018","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.052_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0b013e318270362c","article-title":"Potential intussusception risk versus benefits of rotavirus vaccination in the United States","volume":"32","author":"Desai","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"52","key":"10.1016\/j.vaccine.2020.10.052_b0280","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1016\/j.vaccine.2007.10.009","article-title":"The cost-effectiveness of rotavirus vaccination in Australia","volume":"25","author":"Newall","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.052_b0285","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/21645515.2016.1245252","article-title":"Economic evaluation of routine infant rotavirus immunisation program in Japan","volume":"13","author":"Hoshi","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"35","key":"10.1016\/j.vaccine.2020.10.052_b0290","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1016\/j.vaccine.2019.07.030","article-title":"Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: a South Korean study","volume":"37","author":"Lee","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.052_b0295","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2016.11.056","article-title":"Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia","volume":"35","author":"Reyes","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.052_b0300","doi-asserted-by":"crossref","first-page":"ofz117","DOI":"10.1093\/ofid\/ofz117","article-title":"Systematic review and meta-analysis of cost-effectiveness of rotavirus vaccine in low-income and lower-middle-income countries","volume":"6","author":"Haider","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.10.052_b0305","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/INF.0000000000000723","article-title":"Impact of rotavirus vaccination on childhood hospitalization for seizures","volume":"34","author":"Pardo-Seco","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"1 Suppl","key":"10.1016\/j.vaccine.2020.10.052_b0310","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/INF.0b013e3181fefdee","article-title":"Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule","volume":"30","author":"Buttery","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.052_b0315","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12879-019-3816-7","article-title":"Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001\u20132016","volume":"19","author":"Baker","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2020.10.052_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042320","article-title":"Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models","volume":"7","author":"Pitzer","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2031361X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2031361X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:52:01Z","timestamp":1759402321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2031361X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X2031361X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluation of the introduction of rotavirus vaccine in Hong Kong","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}